
    
      This is a prospective, observational, study across robotic-assisted and laparoscopic primary
      (non-recurrent) umbilical and incisional hernia repair. The study aims to evaluate pain and
      QOL outcomes through 30 days. During the post-operative period through 30 days, pain
      medication intake, subject reported pain and quality of life and incidence of intra-operative
      and post-operative adverse events related to the ventral hernia repair will be collected.
    
  